Introducing Synapse, Patsnap's novel AI powered lifescience platform

2023-04-19

研发

·原创

Introducing Synapse, Patsnap's novel AI powered lifescience platform. Synapse enables you to connect your workflow between Drug Discovery and Drug Development insights. See how seamless and easy it is to use Synapse as we explore Novo Nordisk's Drug pipeline.Simply search for Novo Nordisk in Synapse and click the "View Detail" button to access comprehensive technical information. Novo Nordisk's representative drug types include small molecular drugs, small interfering RNA, hormone, synthetic peptide and biological products. Click on any drug type, such as "small interfering RNA", to uncover more details and gain valuable insights. Synapse lets you analyze and explore small interfering RNA from multiple perspectives, including their highest research and development status. You can check the number of drugs in different stages of research and development on a diagram or select a specific indication, such as cardiovascular diseases, to quickly see the number of drugs in different stages of research and development. This method can be applied to other technology platforms as well, enabling you to quickly and easily compare your research with others in the field. Synapse also provides insights into Novo Nordisk's most commonly developed targets, such as INSR and GLP-1R. Clicking on a target will reveal drugs and their development stages, providing a clear picture of Novo Nordisk's overall research efforts.For a comprehensive overview of Novo Nordisk's entire pipeline, check out the latest snapshot. Whether you're looking to expedite your research projects, identify potential partners, or keep tabs on competitors in the drug research and development space, Synapse has got you covered. Sign up for PatSnap Synapse free today by clicking the link in the description bar. Experience a more innovative approach to intelligence gathering with Synapse!

机构